To prepare the content, the following materials were used:

  1. FDA Substance Registration System
  2. Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
  3. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
  4. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
  5. An overview of alcohol and other drug issues
  6. Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
  7. The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
  8. Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
  9. Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
  10. Schedules of Controlled Substances: Placement of Methylone Into Schedule I
  11. Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
  12. New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
  13. Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
  14. Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
  15. Synthetic cannabinoids in Europe
  16. Pharmacological Effects of MDMA in Man. By Enno Freye
  17. Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
  18. DEA Drug Scheduling
  19. Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
  20. Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
  21. Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
  22. Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
  23. FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
  24. ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
  25. Controlled Substances Act
  26. The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
  27. Cannabis: domestic cultivation widespread
  28. A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics

The content of this site was prepared by experienced rewriters using the most advanced articles and publications written by Vishwadeep Ahluwalia, PhD. VIRGINIA COMMONWEALTH UNIVERSITY. Linkedin